StonvexLoading…
StonvexStonvexStonvexCore line items from VMC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.94B | $7.42B | $7.78B | $7.32B |
Operating Income | $1.62B | $1.36B | $1.43B | $951.40M |
Net Income | $1.08B | $911.90M | $933.20M | $575.60M |
EPS (Diluted) | $8.11 | $6.85 | $6.98 | $4.31 |
Total Assets | $16.70B | $17.10B | $14.55B | $14.23B |
Total Liabilities | $8.15B | $8.96B | $7.04B | $7.28B |
Cash & Equivalents | $183.30M | $559.70M | $931.10M | $161.40M |
Free Cash Flow OCF − CapEx | $1.14B | $806.10M | $664.20M | $535.60M |
Shares Outstanding | 130.60M | 132.10M | 132.10M | 132.90M |